mprF mutations in methicillin-resistant Staphylococcus aureus confer reduced susceptibility to biocides and daptomycin
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 30(2024), 4 vom: 27. März, Seite 552-553 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Mengzhen [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.cmi.2023.12.021 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366324802 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM366324802 | ||
003 | DE-627 | ||
005 | 20240325234536.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231227s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cmi.2023.12.021 |2 doi | |
028 | 5 | 2 | |a pubmed24n1346.xml |
035 | |a (DE-627)NLM366324802 | ||
035 | |a (NLM)38141823 | ||
035 | |a (PII)S1198-743X(23)00629-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Mengzhen |e verfasserin |4 aut | |
245 | 1 | 0 | |a mprF mutations in methicillin-resistant Staphylococcus aureus confer reduced susceptibility to biocides and daptomycin |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.03.2024 | ||
500 | |a Date Revised 25.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Antiseptics | |
650 | 4 | |a Daptomycin | |
650 | 4 | |a Methicillin-resistant Staphylococcus aureus | |
650 | 4 | |a Polyhexamethylene biguanide/polyhexanide | |
650 | 4 | |a mprF | |
650 | 7 | |a Daptomycin |2 NLM | |
650 | 7 | |a NWQ5N31VKK |2 NLM | |
650 | 7 | |a Disinfectants |2 NLM | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Bacterial Proteins |2 NLM | |
700 | 1 | |a Wang, Haiping |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Shengnan |e verfasserin |4 aut | |
700 | 1 | |a Ji, Shujuan |e verfasserin |4 aut | |
700 | 1 | |a Yu, Yunsong |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases |d 1995 |g 30(2024), 4 vom: 27. März, Seite 552-553 |w (DE-627)NLM094580014 |x 1469-0691 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2024 |g number:4 |g day:27 |g month:03 |g pages:552-553 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cmi.2023.12.021 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2024 |e 4 |b 27 |c 03 |h 552-553 |